Reaction

Lacrimal Structure Injury reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 373 reports · 5 co-occurring drugs

As of the last recalculation, Lacrimal Structure Injury appears in 373 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is DOCETAXEL ANHYDROUS (PRR 755.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Docetaxel Anhydrous265755.4758.3
Docetaxel265755.3758.3
Pertuzumab59143.7144.0
Trastuzumab8082.582.6
Carboplatin7037.637.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.